EU Commission to part-fund authorities’ medtech market surveillance programs
This article was originally published in Clinica
The national competent authorities responsible for market surveillance of medical devices in EU and EFTA/EEA countries are going to be eligible in future to receive financial support from the European Commission.
You may also be interested in...
Updated medtech notified body figures from the European Commission always make headline news. But industry needs to see real appointments now, not a list of tricky-to-understand numbers.
Erik Hansson remains deputy head of devices in a move to the European Commission’s DG Sante from DG Grow. He now answers to a newly appointed devices head who shares a common educational background but whose recent pharmaceutical role may unsettle the devices industry.
Companion diagnostics are needed increasingly by pharma companies to justify the safety and effectiveness of their products. With specific first-time EU regulation of these products within sight – and urgently needed – is there a risk of delays to these products being able to demonstrate compliance?